MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma

Liver International

Volumn 32, Issue 10, 2012, Pages 1505-1509

  Zhou, Yan Ming ^a   Zhang, Xiao Feng ^b   Cao, Lu ^b   Li, Bin ^a   Sui, Cheng Jun ^b   Li, Yu Min ^c   Yin, Zheng Feng ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Minichromosome maintenance 7; Prognosis

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN 7; SORAFENIB;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PROGNOSIS; PROTEIN EXPRESSION;

BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PROGNOSIS; PYRIDINES; TUMOR MARKERS, BIOLOGICAL;

EID: 84867103416     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02846.x     Document Type: Article

References (22)

1. Llovet JM, Burroughs A, Bruix J Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Lau WY, Lai EC Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7: 237-57.
3. Sanchez-Berrondo J, Mesa P, Ibarra A, et al. Molecular architecture of a multifunctional MCM complex. Nucleic Acids Res 2012; 40: 1366-80.
4. Tsai HY, Hsi BL, Hung IJ, et al. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections. Hum Pathol 2004; 35: 1397-403.
5. Honeycutt KA, Chen Z, Koster MI, et al. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene 2006; 25: 4027-32.
6. Nishihara K, Shomori K, Fujioka S, et al. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol 2008; 33: 245-51.
7. Ren B, Yu G, Tseng GC, et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006; 25: 1090-8.
8. Lau KM, Chan QK, Pang JC, et al. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion. Oncogene 2010; 29: 5475-89.
9. Ota T, Clayton AC, Minot DM, et al. Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. Mod Pathol 2011; 24: 277-87.
10. Marnerides A, Vassilakopoulos TP, Boltetsou E, et al. Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma. Anticancer Res 2011; 31: 3585-94.
11. Toyokawa G, Masuda K, Daigo Y, et al. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Mol Cancer 2011; 10: 65.
12. Edmondson HA, Steiner PE Primary carcinoma of the liver. A study of 100 cases among 48, 900 necropsies. Cancer 1954; 7: 462-503.
13. Lu W, Dong J, Huang Z, et al. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: okuda, CLIP TNM and CUPI. J Gastroenterol Hepatol 2008; 23: 1874-8.
14. Shi YK, Yu YP, Tseng GC, Luo JH Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7. Cancer Gene Ther 2010; 17: 694-9.
15. Sterner JM, Dew-Knight S, Musahl C, Kornbluth S, Horowitz JM Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol 1998; 18: 2748-57.
16. Shi YK, Yu YP, Zhu ZH, et al. MCM7 interacts with androgen receptor. Am J Pathol 2008; 173: 1758-67.
17. Han YC, Yu YP, Nelson J, et al. Interaction of integrin-linked kinase and miniature chromosome maintenance 7-mediating integrin {alpha}7 induced cell growth suppression. Cancer Res 2010; 70: 4375-84.
18. Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003; 17: 1115-29.
19. Ng SA, Lee C Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 2011; 46: 974-90.
20. Yang L, He J, Chen L, Wang G Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med Oncol 2009; 26: 445-51.
21. Tamura T, Shomori K, Haruki T, et al. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study. J Oral Pathol Med 2010; 39: 328-34.
22. el Tazi M, Essadi I, M'rabti H, Touyar A, Errihani PH Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci 2011; 3: 167-75.